Yes, vaccinated people are catching omicron. However, vaccination - and especially vaccination with boosting - makes you less likely to catch it, less likely to spread it, and much less likely to be hospitalized or die from omicron.
Our paper on Omicron is out in the New England Journal of Medicine. Antibodies in people who got 2 doses of Moderna's vaccine are much worse at recognizing omicron, compared to other variants. Booster dose helps a lot. https://t.co/3XitrSBGxF
Our paper with initial data on Covid - Omicron is on Medrxiv in record time, and Dr Fauci showed my data slide today!!! Vaccine-induced antibodies are weak against omicron, but boosts help a lot.
https://t.co/5EPF8nGDq0
There have been a number of overview threads on the emerging variant designated as @PangoNetwork lineage B.1.1.529, @nextstrain clade 21K and @WHO Variant of Concern Omicron. I'm not going to attempt to be comprehensive here, but will highlight a few aspects of the data. 1/16
The chance of kids getting myocarditis from Covid-19 are greater than from the vaccine, says Kizzmekia Corbett, the scientist who helped develop the Moderna vaccine.
Parents should ask if they prefer their children have "antibodies ready to fight off this virus or not."
Great article by @Carolynyjohnson about my friend and colleague @BarneyGrahamMD, who just recently retired from the VRC. Looking forward to his visit to UT Austin in 2 weeks. I hope he's ready for some @franklinbbq!
I woke up, made myself a pseudo-charcuterie and made a “To boost or not to boost” flowchart for the people who, appropriately, are confused.
*disclaimer* I thought about having wine, but didn’t… yet. #vinoology#virology
The majority of individuals who received both doses of the mRNA-1273 (Moderna) vaccine maintained binding and functional antibodies against #SARSCoV2 variants for six months, a new Science study shows. Read more: https://t.co/msundlOfFF
The majority of individuals who received both doses of the mRNA-1273 (Moderna) vaccine maintained binding and functional antibodies against #SARSCoV2 variants for six months, a new Science study shows. https://t.co/jf98Rgasop
https://t.co/kRbQmKfp3W
Our new study on the Moderna vaccine vs viral variants. Over half of subjects in the Phase 1 trial still had neutralizing antibodies against B.1.351 and other variants at six months after the second dose of vaccine.
Super excited to release this animation showing how SARS-CoV-2 gets into cells. The video below shows just a small segment of the full animation. To get to a link to see the entire thing and to read more about the project, go to https://t.co/JiLSA5Kut6